BACKGROUND: The burden of breast cancer is important for the healthcare system. In the context of the evaluation of the breast cancer screening program in the Basque Country it is important to determine the unitary costs related to diagnosis as well as the treatment costs depending on the clinical stage at detection. The main objective was to calculate the total cost and the components of breast cancer (BC) treatment depending on the clinical stage by 2011. METHODS: The estimated costs include BC diagnosis as so as to initial treatment and follow-up, based on resource consumption and unitary costs of the Basque Health Services. Micro-costing technique was applied based on the clinical guidelines. RESULTS: Our model showed the estimated loss of productivity due to premature The initial cost was 9.838 for the stage 0, 17.273 for stage I, 22.145 for stage II and 28.776 for stage III. The follow up annual cost was 172 for the stage 0, 908 for stage I, 994 for stage II and 1.166 for stage III. The annual cost for stage IV was 17879. CONCLUSIONS: Chemotherapy determines the greatest percentage of BC costs. The two main drivers of the total cost of breast cancer are the initial treatment of stages I to III and the cost of stage IV, the latter reaching 50,061 per patient.
BACKGROUND: The burden of breast cancer is important for the healthcare system. In the context of the evaluation of the breast cancer screening program in the Basque Country it is important to determine the unitary costs related to diagnosis as well as the treatment costs depending on the clinical stage at detection. The main objective was to calculate the total cost and the components of breast cancer (BC) treatment depending on the clinical stage by 2011. METHODS: The estimated costs include BC diagnosis as so as to initial treatment and follow-up, based on resource consumption and unitary costs of the Basque Health Services. Micro-costing technique was applied based on the clinical guidelines. RESULTS: Our model showed the estimated loss of productivity due to premature The initial cost was 9.838 for the stage 0, 17.273 for stage I, 22.145 for stage II and 28.776 for stage III. The follow up annual cost was 172 for the stage 0, 908 for stage I, 994 for stage II and 1.166 for stage III. The annual cost for stage IV was 17879. CONCLUSIONS: Chemotherapy determines the greatest percentage of BC costs. The two main drivers of the total cost of breast cancer are the initial treatment of stages I to III and the cost of stage IV, the latter reaching 50,061 per patient.
Authors: S Pérez Ramírez; M Del Monte-Millán; S López-Tarruella; N Martínez Jáñez; I Márquez-Rodas; F Lobo Samper; Y Izarzugaza Perón; C Rubio Terres; D Rubio Rodríguez; J Á García-Sáenz; F Moreno Antón; P Zamora Auñón; M Arroyo Yustos; M Á Lara Álvarez; E M Ciruelos Gil; L Manso Sánchez; M J Echarri González; J A Guerra Martínez; C Jara Sánchez; C Bueno Muiño; S García Adrián; J R Carrión Galindo; V Valentín Maganto; M Martín Journal: Clin Transl Oncol Date: 2019-07-12 Impact factor: 3.405
Authors: Concepción Pérez-Hernández; Antonio Javier Jiménez-López; Almudena Sanz-Yagüe; Javier Mar-Medina; Igor Larrañaga; Begoña Soler-López Journal: Pain Ther Date: 2018-07-05
Authors: Arantzazu Arrospide; Montserrat Rue; Nicolien T van Ravesteyn; Merce Comas; Myriam Soto-Gordoa; Garbiñe Sarriugarte; Javier Mar Journal: BMC Cancer Date: 2016-06-01 Impact factor: 4.430
Authors: Arantzazu Arrospide; Montserrat Rue; Nicolien T van Ravesteyn; Merce Comas; Nerea Larrañaga; Garbiñe Sarriugarte; Javier Mar Journal: BMC Cancer Date: 2015-10-12 Impact factor: 4.430